MAP PHARMACEUTICALS, INC. Comprehensive Income
MAP PHARMACEUTICALS, INC. reported Comprehensive Income of -$12.62 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-09-30 was -$12.62M, a 254.25% decline year-over-year.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-06-30 was -$13.29M.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-03-31 was -$17.84M.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2011-12-31 was -$13.82M.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was -$32.94M.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was -$54.67M.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2009 was -$9.04M.
- MAP PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2008 was -$73.06M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 105 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 108 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 111 month |
|---|---|---|---|---|---|---|---|
| 2012-09-30 | -$12.62M 10-Q · filed 2012-11-06 | -$25.91M derived: sum of 2 quarters · filed 2012-11-06 | -$43.76M 10-Q · filed 2012-11-06 | -$57.58M derived: sum of 4 quarters · filed 2012-11-06 | -$304.24M 10-Q · filed 2012-11-06 | ||
| 2012-06-30 | -$13.29M 10-Q · filed 2012-07-27 | -$31.14M 10-Q · filed 2012-07-27 | -$44.95M derived: sum of 3 quarters · filed 2012-07-27 | -$36.77M derived: sum of 4 quarters · filed 2012-11-06 | -$305.55M 10-Q · filed 2012-07-27 | ||
| 2012-03-31 | -$17.84M 10-Q · filed 2012-05-08 | -$31.66M derived: sum of 2 quarters · filed 2012-05-08 | -$23.48M derived: sum of 3 quarters · filed 2012-11-06 | -$34.78M derived: sum of 4 quarters · filed 2012-11-06 | -$278.33M 10-Q · filed 2012-05-08 | ||
| 2011-12-31 | -$13.82M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$5.64M derived: sum of 2 quarters · filed 2012-11-06 | -$16.94M derived: sum of 3 quarters · filed 2012-11-06 | -$32.94M 10-K · filed 2012-03-30 | |||
| 2011-09-30 | $8.18M 10-Q · filed 2012-11-06 | -$3.12M derived: sum of 2 quarters · filed 2012-11-06 | -$19.12M 10-Q · filed 2012-11-06 | ||||
| 2011-06-30 | -$11.30M 10-Q · filed 2012-07-27 | -$27.30M 10-Q · filed 2012-07-27 | |||||
| 2011-03-31 | -$16.00M 10-Q · filed 2012-05-08 | ||||||
| 2010-12-31 | -$54.67M 10-K · filed 2012-03-30 | ||||||
| 2009-12-31 | -$9.04M 10-K · filed 2012-03-30 | ||||||
| 2008-12-31 | -$73.06M 10-K · filed 2012-03-30 | ||||||
| 2007-12-31 | -$39.88M 10-K · filed 2012-03-30 | ||||||
| 2006-12-31 | -$25.80M 10-K · filed 2012-03-30 |